The Korean market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. The Korean market for implantable ports has been growing slightly due to a shift away from conventional and towards power-injectable implantable ports. This growth is moderated by strong declines in ASPs for power-injectable implantable ports as competitors are expecting strong growth for this segment. Currently, the power-injectable implantable ports segment accounted for a majority share of the total implantable ports market. Over the forecast period, power-injectable ports are expected to take an even greater share of the overall market.
The South Korean market for peripheral intravenous catheters (PIVCs) is split up into two segments: conventional PIVC and safety PIVC. PIVCs are inserted in veins and arteries. An arterial access site is utilized in patients that require blood pressure monitoring. Firmer catheters are preferred for arterial access. A venous access site is utilized for infusing fluids, providing antibiotic treatment and other standard procedures. In 2016, safety PIVCs represented less than 10% of the total market for PIVCs, with the remaining balance is represented by conventional PIVCs. In Korea, conventional PIVCs represent over 90% of the total market. Growth in the unit sales of advanced materials PIVCs is expected to drive gains in the share of safety PIVCs over the forecast period.
The total Korean market for port needles can be segmented by conventional and safety port needles. In 2016, the largest segment in the total port needle market was the conventional port needles, which accounted for more than 70% of the total market value. However, safety port needles are growing while conventional port needles are contracting.
iData provides one of the most comprehensive and efficient market research survey services in the world using a 5-step methodology. Whether it is to gauge end-user behavior regarding new or existing products, competitors products, purchasing habits, marketing penetration/effectiveness rates, ad testing or obtaining statistically significant quantitative data on specific products and services, iDatas survey team is equipped and ready to engage.
In 2016, the Indian market for dialysis catheters increased over the previous year. The market for dialysis catheters is experiencing significant growth due to the growing incidence of end-stage renal disease and the need for dialysis. This growth has led to a dramatic rise in clinics offering dialysis. The growth has had a negative effect on the quality of care. In an effort to make profits, quality of care has deteriorated, with a significant percentage of hospitals and clinics not having dialysis specialists among their staff. The market for dialysis catheters will continue to grow as ASPs for a dialysis catheter continue to fall at low-single digit rates due to increased competition from low-cost producers from the local markets in India, as well as foreign competitors in Korea and China.
The Indian market for implantable ports comprises conventional implantable ports and power-injectable implantable ports. Conventional implantable ports are defined as implantable ports that do not feature power-injection. Currently, the conventional implantable ports segment accounted for about 60% of the total implantable ports market. Over the forecast period, the market breakdown is expected to change slightly but conventional devices will still consist of majority of the market.
The Indian market for peripherally inserted central catheters (PICCs) is split up into two segments: power-injectable and conventional PICCs. Conventional PICCs are defined as PICCs that do not feature power-injection or antimicrobial properties. Although power-injectable PICCs have become the standard of care in some countries such as the United States, India still prefers conventional PICCs and is over ten years behind most developed countries. In 2016, power-injectable PICCs represented only 20% of the total market for PICCs, with the remaining balance represented by conventional PICCs. Growth in the unit sales of advanced materials PICCs is expected to drive gains in the share of power-injectable PICCs over the forecast period.
The Indian market for peripheral intravenous catheters (PIVCs) is split up into 2 segments: conventional PIVC and safety PIVC. PIVCs are inserted in veins and arteries. An arterial access site is utilized in patients that require blood pressure monitoring. Firmer catheters are preferred for arterial access. A venous access site is utilized for infusing fluids, providing antibiotic treatment and other standard procedures. In 2016, safety PIVCs represented 12% of the total market for PIVCs, with the remaining balance represented by conventional PIVCs. Growth in the unit sales of advanced materials PIVCs is expected to drive gains in the share of safety PIVCs over the forecast period.
The total Indian market for port needles can be segmented by conventional and safety port needles. In 2016, the largest segment in the total port needle market was the conventional port needles, which accounted for more than 93% of the total market value. However, safety port needles are growing at a much faster pace than conventional port needles. Conventional port needles are expected to continue its dominance in the port needle market in the foreseeable future.
After catheters are placed, they must be secured to prevent catheter migration, pistoning or dislodgement. Minor catheter movements can irritate the vein and cause phlebitis, while larger movements can create dislodgement and cause catheter infiltration and possibly infection. These problems can create a need for catheter replacement, which increases both cost and the chance of needlestick injury. All catheters require some form of securement, which varies depending on the catheter and healthcare facility.
Dialysis catheters are used for facilitating dialysis for patients whose kidneys are unable to properly filter water and waste. Most patients treated with dialysis have been diagnosed with end-stage renal disease (ESRD); however, patients suffering from acute kidney failure can also receive dialysis. Glomerular filtration rate (GFR) is a test used to assess kidney function. In turn, patients with chronically low GFRs are diagnosed with chronic kidney disease (CKD). When the GFR drops below the threshold, which is when kidney activity is less than 10% of normal levels, patients are considered to have progressed to Stage 5 CKD or ESRD. Patients with ESRD require a kidney transplant or dialysis. However, many ESRD patients are not suitable candidates for kidney transplants.
The implantable port market comprises conventional and power-injectable implantable ports. Power-injectable implantable ports are capable of withstanding higher pressures than conventional implantable ports in order to facilitate the injection of contrast dye for computed tomography (CT) scan procedures. If a patient has a conventional implantable port and requires a medical scan, the port must be removed and replaced with a power-injectable port.
Peripherally inserted central catheters (PICCs) are introduced through the basilic, cephalic or median cubital veins in the arm, and the tip of the catheter is then directed to the superior vena cava (SVC). PICCs have a wide range of applications and are commonly used for delivering chemotherapy and antibiotics, and for drawing blood. Generally, the devices are used for one week to three months but can range in use from a few days to over a year. This flexibility sets PICCs apart from other vascular access catheters and contributes to the increased use of PICCs in general. The most frequent indwelling time for a PICC is three weeks. Although the number of PICC procedures is relatively small compared with those involving central venous catheters (CVCs), PICCs are taking market share away from other catheter types. This is due to the fact that PICCs are associated with a lower infection rate in comparison to CVCs.
Peripheral intravenous catheters (PIVCs), also known as short peripheral IV catheters, are the most commonly used type of vascular access catheters. Almost 90% of patients admitted to hospitals receive a vascular access device, the vast majority of which are PIVCs. These devices are intended for short-term use, usually no longer than three days, and are inserted into the median cubital vein or the forearm extending for only a few inches. Owing to their peripheral placement, these catheters cannot be used for infusing toxic, irritating or vesicant drugs, including most of those used for chemotherapy. The flow rates of PIVCs are lower than central line catheters, such as central venous catheters (CVCs), making them best suited for blood sampling and infusing fluids and medicine.
The European market for port needles include conventional and safety port needles. Safety port needles include power-injectable and non-power-injectable port needles that feature a needlestick prevention mechanism. The value of the port needle market has appreciated in recent years. The implementation of legislation designed to prevent needlestick injuries in hospitals has led to increasing sales of safety port needles and a spike in the overall port needle market from 2012.
Syringes and needles were the first devices used for vascular access, and they are still widely used in Europe. Syringes are used for a variety of applications, including percutaneous injections, injection into catheters, preparation and transport of drugs, blood draws and non-medical applications. Needles connect to syringes and are used for gaining vascular access. They can be sold in combination with syringes or separately. With the aid of needleless connectors such as Luer locks, syringes can be used without needles.